SEVTIMBO
Live / Applied — Second extension granted (statement of use) (as of 07 Nov 2025)
What this means for you
Not registered yet, but its 01 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98528952
- Mark type
- Stylized text
- Filed
- 01 May 2024
- Published for opposition
- 15 Oct 2024
- Attorney of record
- Janet W. Cho
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, proteasome inhibitors; pharmaceutical preparations for treatment of myelomas, leukemias, and cancers; pharmaceutical preparations for use in chemotherapy
Owner
- Amneal Pharmaceuticals LLC, Bridgewater, NJ, US
- Amneal Pharmaceuticals LLC, Bridgewater, NJ, US
Prosecution history
- 08 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Nov 2025 — SOU EXTENSION 2 GRANTED
- 07 Nov 2025 — SOU EXTENSION 2 FILED
- 07 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 24 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2025 — SOU EXTENSION 1 GRANTED
- 23 May 2025 — SOU EXTENSION 1 FILED
- 23 May 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2024 — PUBLISHED FOR OPPOSITION
- 25 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Sept 2024 — ASSIGNED TO EXAMINER
- 01 May 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED